Vbi Vaccines Inc/bc
VBIVQ
Revenue
1.21M
▲361.00k▲42.32%
3 Months ChangeAssets
75.44M
▼-11.51M▼-13.24%
3 Months ChangeLiabilities
80.91M
▲1.49M▲1.87%
3 Months ChangeFree Cash Flow
-11.92M
▲10.27M▲46.28%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-02
Form 8-K
ID: 0001493152-24-030073
2024-07-30
Form 8-K
ID: 0001493152-24-029537
2024-06-25
Form 8-K
ID: 0001493152-24-025093
2024-05-29
Form 8-K
ID: 0001493152-24-021727
2024-05-24
Form 8-K
ID: 0001493152-24-021392
2024-05-15
Form 8-K
ID: 0001493152-24-019881
2024-05-15
Form 10-Q
ID: 0001493152-24-019796
2024-05-01
Form 8-K
ID: 0001493152-24-017420
2024-04-16
Form 8-K
ID: 0001493152-24-014743
2024-04-11
Form 8-K
ID: 0001493152-24-014323